Literature DB >> 11756950

Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1.

Larisa C Kelley1, Laurie Starkus.   

Abstract

BACKGROUND: Lentigo maligna (LM) often displays extensive subclinical spread. Mohs micrographic surgery (MMS) has been proposed to help delineate the true histologic margin; however, visualizing atypical melanocytes on frozen section is challenging and often requires confirmatory permanent paraffin sections.
OBJECTIVE: Our aim was to use a monoclonal antibody to rapidly stain frozen sections during MMS to facilitate better visualization of atypical melanocytes.
METHODS: Frozen sections of LM during MMS were stained with MART-1 (melanoma antigen recognized by T cells) and compared with paraffin-embedded sections.
RESULTS: We found 100% correlation between frozen sections stained with MART-1 and paraffin-embedded sections.
CONCLUSIONS: Atypical melanocytes can be better visualized on frozen sections of LM by using MART-1 rather than hematoxylin and eosin. This allows for easier identification during MMS and better chance of complete removal of LM lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756950     DOI: 10.1067/mjd.2002.119197

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Implementation of fluorescence confocal mosaicking microscopy by "early adopter" Mohs surgeons and dermatologists: recent progress.

Authors:  Manu Jain; Milind Rajadhyaksha; Kishwer Nehal
Journal:  J Biomed Opt       Date:  2017-02-01       Impact factor: 3.170

Review 2.  Mohs Micrographic Surgery: Development, Technique, and Applications in Cutaneous Malignancies.

Authors:  Eillen Luisa A Chen; Divya Srivastava; Rajiv I Nijhawan
Journal:  Semin Plast Surg       Date:  2018-05-14       Impact factor: 2.314

3.  Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.

Authors:  Sheila M Valentín-Nogueras; David G Brodland; John A Zitelli; Lorena González-Sepúlveda; Cruz M Nazario
Journal:  Dermatol Surg       Date:  2016-06       Impact factor: 3.398

Review 4.  Histopathologic pitfalls of Mohs micrographic surgery and a review of tumor histology.

Authors:  Katlein França; Yasser Alqubaisy; Ashraf Hassanein; Keyvan Nouri; Torello Lotti
Journal:  Wien Med Wochenschr       Date:  2016-11-10

5.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 6.  Guidelines of the Brazilian Dermatology Society for diagnosis, treatment and follow up of primary cutaneous melanoma--Part I.

Authors:  Luiz Guilherme Martins Castro; Maria Cristina Messina; Walter Loureiro; Ricardo Silvestre Macarenco; João Pedreira Duprat Neto; Thais Helena Bello Di Giacomo; Flávia Vasques Bittencourt; Renato Marchiori Bakos; Sérgio Schrader Serpa; Hamilton Ometto Stolf; Gabriel Gontijo
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

7.  Expression of soluble adenylyl cyclase in lentigo maligna: use of immunohistochemistry with anti-soluble adenylyl cyclase antibody (R21) in diagnosis of lentigo maligna and assessment of margins.

Authors:  Cynthia M Magro; Sung-Eun Yang; Jonathan H Zippin; Artur Zembowicz
Journal:  Arch Pathol Lab Med       Date:  2012-12       Impact factor: 5.534

8.  Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series.

Authors:  Daniel Garcia; Robert E Eilers; S Brian Jiang
Journal:  J Clin Investig Dermatol       Date:  2017-02-27

Review 9.  Current perspectives on Mohs micrographic surgery for melanoma.

Authors:  Derek Beaulieu; Ramin Fathi; Divya Srivastava; Rajiv I Nijhawan
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.